Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.
about
Patient-derived tumour xenografts as models for oncology drug developmentCurrent status and evolution of preclinical drug development models of epithelial ovarian cancerStability of preclinical models of aggressive renal cell carcinomas.Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testingEstablishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.Development of a realistic in vivo bone metastasis model of human renal cell carcinomaA validated tumorgraft model reveals activity of dovitinib against renal cell carcinomaCancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinomaOrigin of the vasculature supporting growth of primary patient tumor xenografts.Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)Nephroblastoma overexpressed gene expression and its prognostic implications of clinical outcomes in renal cell carcinoma patients.Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivoDovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI.
P2860
Q24604068-6D49F567-9698-4652-A719-87B2C73E999CQ27028117-BBBB682A-F6D0-43BA-9C89-43772B240E1FQ33898564-AAB5DFF5-29D2-4277-8906-77F845BD6904Q35041892-C1EDF6F3-43AE-4DEE-9B7F-CF7D4246CD94Q35119526-82D32E4B-0D54-4A17-A87E-A9802E20FADAQ35150788-665300E7-0220-4C14-83A6-EC9370345AEEQ35154534-0148B0B6-A1D3-48ED-BFE2-657BC1A3C094Q36606040-D71A3180-2A87-4A8C-B654-7941642F16CAQ36845660-841A53E9-DD6C-44AD-88CC-A12EB46329D1Q36863454-2F717AC1-83E9-4987-B61E-2DA47EAEAC80Q37017045-6A942486-FB50-4893-89C7-12A4274EFF9DQ38628825-16200EFF-216A-4A1D-8B19-C1E9AEA7EBE4Q38865279-6CC7CC32-296E-4C26-AA31-DC7E437EE0D9Q39062384-863992BB-9143-47CE-A98D-C1FC3A3FB424Q47148716-97545321-0EF9-4838-AA2F-A80913A7B182
P2860
Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@en
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@nl
type
label
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@en
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@nl
prefLabel
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@en
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@nl
P2093
P2860
P356
P1476
Orthotopic xenografts of RCC r ...... atures of tumours in patients.
@en
P2093
Andrew Percy
Apryle Seeley
Arianna Di Napoli
Chiara Grisanzio
Michael Collins
Michelle Chang
Rameen Beroukhim
Sabina Signoretti
Su-Chun Cheng
P2860
P304
P356
10.1002/PATH.2929
P577
2011-06-27T00:00:00Z